These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 34144110)

  • 1. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.
    Adir Y; Humbert M; Saliba W
    J Allergy Clin Immunol; 2021 Aug; 148(2):361-367.e13. PubMed ID: 34144110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics.
    Papaioannou AI; Fouka E; Tzanakis N; Antoniou K; Samitas K; Zervas E; Kostikas K; Bartziokas K; Porpodis K; Papakosta D; Tzouvelekis A; Gerogianni I; Kotsiou O; Makris M; Rovina N; Vlachou G; Markatos M; Vittorakis S; Katsoulis K; Papanikolaou I; Afthinos A; Katsaounou P; Steiropoulos P; Latsios D; Dimakou K; Koukidou S; Hillas G; Tryfon S; Kallieri M; Georgopoulou A; Avarlis P; Bakakos P; Markopoulou K; Gaki E; Paspala A; Kyriakaki Z; Gourgoulianis KI; Papiris S; Loukides S
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2588-2595. PubMed ID: 35752436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19.
    Chhiba KD; Patel GB; Vu THT; Chen MM; Guo A; Kudlaty E; Mai Q; Yeh C; Muhammad LN; Harris KE; Bochner BS; Grammer LC; Greenberger PA; Kalhan R; Kuang FL; Saltoun CA; Schleimer RP; Stevens WW; Peters AT
    J Allergy Clin Immunol; 2020 Aug; 146(2):307-314.e4. PubMed ID: 32554082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [COVID-19 and asthma].
    Louis R; Calmes D; Frix AN; Schleich F
    Rev Med Liege; 2020 Sup; 75(S1):130-132. PubMed ID: 33211435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019.
    Timberlake DT; Strothman K; Grayson MH
    Curr Opin Allergy Clin Immunol; 2021 Apr; 21(2):182-187. PubMed ID: 33399389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma.
    Moore WC; Panettieri RA; Trevor J; Ledford DK; Lugogo N; Soong W; Chipps BE; Carr W; Belton L; Gandhi H; Trudo F; Ambrose CS
    Ann Allergy Asthma Immunol; 2020 Sep; 125(3):294-303.e1. PubMed ID: 32304877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe asthma and COVID-19: lessons from the first wave.
    Patrucco F; Benfante A; Villa E; Principe S; Scichilone N; Solidoro P
    J Asthma; 2022 Feb; 59(2):239-242. PubMed ID: 33297799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?
    Kumar K; Hinks TSC; Singanayagam A
    Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1244-L1247. PubMed ID: 32401670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma and COVID-19: an update.
    Adir Y; Saliba W; Beurnier A; Humbert M
    Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34911694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma, biologics, corticosteroids, and coronavirus disease 2019.
    Akenroye AT; Wood R; Keet C
    Ann Allergy Asthma Immunol; 2020 Jul; 125(1):12-13. PubMed ID: 32387535
    [No Abstract]   [Full Text] [Related]  

  • 11. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
    Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma in the era of SARS CoV-2 virus.
    Bakakos A; Krompa A
    J Asthma; 2022 Aug; 59(8):1501-1508. PubMed ID: 34112029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of anxiety during the COVID-19 pandemic as a risk factor of clinical worsening in patients with severe asthma.
    Lacwik P; Szydłowska D; Kupczyk M; Pałczyński C; Kuna P
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1381-1383. PubMed ID: 33440258
    [No Abstract]   [Full Text] [Related]  

  • 14. The course of COVID-19 in patients with severe asthma receiving biological treatment.
    Tuncay G; Cakmak ME; Can Bostan O; Kaya SB; Damadoglu E; Karakaya G; Kalyoncu AF
    J Asthma; 2022 Nov; 59(11):2174-2180. PubMed ID: 34669544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of biologics in severe asthmatic patients with SARS-CoV-2 infection: A prospective study.
    Manti S; Giallongo A; Pecora G; Parisi GF; Papale M; Mulè E; Aloisio D; Rotolo N; Leonardi S
    Pediatr Pulmonol; 2023 Apr; 58(4):1085-1091. PubMed ID: 36593591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry.
    Chen W; Tran TN; Sadatsafavi M; Murray R; Wong NCB; Ali N; Ariti C; Bulathsinhala L; Gil EG; FitzGerald JM; Alacqua M; Al-Ahmad M; Altraja A; Al-Lehebi R; Bhutani M; Bjermer L; Bjerrum AS; Bourdin A; von Bülow A; Busby J; Canonica GW; Carter V; Christoff GC; Cosio BG; Costello RW; Fonseca JA; Gibson PG; Yoo KH; Heaney LG; Heffler E; Hew M; Hilberg O; Hoyte F; Iwanaga T; Jackson DJ; Jones RC; Koh MS; Kuna P; Larenas-Linnemann D; Lehmann S; Lehtimäki L; Lyu J; Mahboub B; Maspero J; Menzies-Gow AN; Newell A; Sirena C; Papadopoulos NG; Papaioannou AI; Perez-de-Llano L; Perng Steve DW; Peters M; Pfeffer PE; Porsbjerg CM; Popov TA; Rhee CK; Salvi S; Taillé C; Taube C; Torres-Duque CA; Ulrik C; Ra SW; Wang E; Wechsler ME; Price DB
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2732-2747. PubMed ID: 37301430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologics may have a beneficial effect in asthma patients with COVID-19.
    Izquierdo JL; Soriano JB
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 34244322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Asthma Health Care Utilization, Viral Testing, and Air Pollution Changes During the COVID-19 Pandemic.
    Taquechel K; Diwadkar AR; Sayed S; Dudley JW; Grundmeier RW; Kenyon CC; Henrickson SE; Himes BE; Hill DA
    J Allergy Clin Immunol Pract; 2020; 8(10):3378-3387.e11. PubMed ID: 32827728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection with SARS-CoV-2 among children with asthma: evidence from Global Asthma Network.
    Chiang CY; Ellwood P; Ellwood E; García-Marcos L; Masekela R; Asher I; Badellino H; Sanz AB; Douros K; El Sony A; Diaz CG; Rodríguez MA; Moreno-Salvador A; Pérez-Martini LF; Filho NR; Shpakou A; Sulaimanov S; Tavakol M; Valverde-Molina J; Yousef AA; Pearce N;
    Pediatr Allergy Immunol; 2022 Jan; 33(1):e13709. PubMed ID: 34856034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe asthma exacerbations in the United States:: Incidence, characteristics, predictors, and effects of biologic treatments.
    Trevor J; Lugogo N; Carr W; Moore WC; Soong W; Panettieri RA; Desai P; Trudo F; Ambrose CS
    Ann Allergy Asthma Immunol; 2021 Nov; 127(5):579-587.e1. PubMed ID: 34273485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.